相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Gene Ontology resource: enriching a GOld mine
Seth Carbon et al.
NUCLEIC ACIDS RESEARCH (2021)
UniProt: the universal protein knowledgebase in 2021
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2021)
Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition
Nicholas C. Cullen et al.
SCIENTIFIC REPORTS (2021)
Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohorts
Flora H. Duits et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid
Gustaf Bostrom et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Changed signals of blood adenosine and cytokines are associated with parameters of sleep and/or cognition in the patients with chronic insomnia disorder
Chong-Yang Ren et al.
SLEEP MEDICINE (2021)
Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis
Sai Krishna Srimadh Bhagavatham et al.
SCIENTIFIC REPORTS (2021)
Inflammatory Biomarkers Aid in Diagnosis of Dementia
Erik B. Erhardt et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
Usma Munawara et al.
IMMUNITY & AGEING (2021)
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics
Lorenzo Gaetani et al.
CELLS (2021)
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
Huiqin Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
Ashvini Keshavan et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease
Alessandra Webers et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms
Anna Santaella et al.
BMC NEUROLOGY (2020)
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Gill Livingston et al.
LANCET (2020)
Adenosine Deaminase as a Useful Biomarker for Diagnosis and Monitoring of Inflammatory Bowel Disease
Mariyana Yordanova et al.
CLINICAL LABORATORY (2020)
The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials
Jeffrey Cummings
ALZHEIMERS & DEMENTIA (2019)
Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke
Camilla Thygesen et al.
EXPERT REVIEW OF PROTEOMICS (2019)
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease
Christopher D. Whelan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline
Ricardo Taipa et al.
NEUROBIOLOGY OF AGING (2019)
Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants
Chao Xuan et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2019)
Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology
Patricia Alonso-Andres et al.
BRAIN PATHOLOGY (2018)
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study
Clifford R. Jack et al.
LANCET NEUROLOGY (2017)
A subcellular map of the human proteome
Peter J. Thul et al.
SCIENCE (2017)
Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population
Daniela Bertens et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator
Carmen Roncal et al.
CARDIOVASCULAR RESEARCH (2017)
Tau: From research to clinical development
David M. Holtzman et al.
ALZHEIMERS & DEMENTIA (2016)
Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation
Ryan S. McMahan et al.
JOURNAL OF IMMUNOLOGY (2016)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles
Sylvain Lehmann et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Inflammatory process in Alzheimer's Disease
Marco A. Meraz-Rios et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2013)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
Bruce A. Yankner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans
JV Rétey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dominant localization of adenosine deaminase in leptomeninges and involvement of the enzyme in sleep
T Okada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)